Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadamu Homma

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Biomedicine & Biotechnology|April 10, 2010
Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cellsShigeo Koido, Sadamu Homma, Eiichi Hara, et al.
Clinical Immunology (Orlando, Fla.)|January 19, 2010
Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammationChisato Saeki, Masanori Nakano, Hiroki Takahashi, et al.
Clinical Lung Cancer|June 4, 2018
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung CancerYusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi, et al.
International Journal of Cancer|June 16, 2004
Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ miceMasaki Irie, Sadamu Homma, Hideo Komita, et al.
Clinical Immunology (Orlando, Fla.)|October 26, 2005
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12Shigeo Tamaki, Sadamu Homma, Yasuyuki Enomoto, et al.
Clinical & Developmental Immunology|February 26, 2010
Cancer vaccine by fusions of dendritic and cancer cellsShigeo Koido, Eiichi Hara, Sadamu Homma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathwayEijiro Nagasaki, Akitaka Takahara, Shigeo Koido, et al.
Anticancer Research|December 11, 2012
Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitroShin Kan, Shoichi Hazama, Kazunari Maeda, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 13, 2018
Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancerNorimitsu Okui, Yuko Kamata, Yukiko Sagawa, et al.
Anticancer Research|May 7, 2013
Identification of HLA class I-binding peptides derived from unique cancer-associated proteins by mass spectrometric analysisYuko Kamata, Akiko Kuhara, Takeo Iwamoto, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Biomedicine & Biotechnology|April 10, 2010
Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cellsShigeo Koido, Sadamu Homma, Eiichi Hara, et al.
Clinical Immunology (Orlando, Fla.)|January 19, 2010
Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammationChisato Saeki, Masanori Nakano, Hiroki Takahashi, et al.
Clinical Lung Cancer|June 4, 2018
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung CancerYusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi, et al.
International Journal of Cancer|June 16, 2004
Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ miceMasaki Irie, Sadamu Homma, Hideo Komita, et al.
Clinical Immunology (Orlando, Fla.)|October 26, 2005
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12Shigeo Tamaki, Sadamu Homma, Yasuyuki Enomoto, et al.
Clinical & Developmental Immunology|February 26, 2010
Cancer vaccine by fusions of dendritic and cancer cellsShigeo Koido, Eiichi Hara, Sadamu Homma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathwayEijiro Nagasaki, Akitaka Takahara, Shigeo Koido, et al.
Anticancer Research|December 11, 2012
Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitroShin Kan, Shoichi Hazama, Kazunari Maeda, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 13, 2018
Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancerNorimitsu Okui, Yuko Kamata, Yukiko Sagawa, et al.
Anticancer Research|May 7, 2013
Identification of HLA class I-binding peptides derived from unique cancer-associated proteins by mass spectrometric analysisYuko Kamata, Akiko Kuhara, Takeo Iwamoto, et al.
Pageof 8